Table 1.
Characteristics of Participants (N = 488)
| Total Sample M ± SD or n(%) | |
|---|---|
| Demographic and Medical | |
| Age | 62.44 ± 10.94 |
| Female | 118 (24.2) |
| Non-Hispanic Caucasian | 461 (94.5) |
| Comorbidity | |
| Cancer | 30 (6.1) |
| Cerebrovascular Disease | 14 (2.9) |
| Type 2 Diabetes | 109 (22.3) |
| Peripheral Artery Disease | 24 (4.9) |
| Previous Myocardial Infarction | 26 (5.3) |
| Pulmonary Disease | 54 (11.1) |
| Renal Disease | 37 (7.6) |
| Baseline METs | 6.48 (2.42) |
| Baseline BMI | 30.58 (5.62) |
| Admission Event | |
| Angina | 12 (2.5) |
| CABG | 67 (13.7) |
| Heart Failure | 24 (4.9) |
| NSTEMI | 89 (18.2) |
| STEMI | 117 (24.0) |
| PCI | 121 (24.8) |
| Valve repair/replacement | 58 (11.9) |
| Number of sessions attended | 33.05 (4.08) |
Note. METs = metabolic equivalents, CABG = coronary artery bypass grafting; NSTEMI = non-ST-elevation myocardial infarction; STEMI = ST-elevation myocardial infarction; PCI = percutaneous coronary intervention.